Stay updated with breaking news from Brian Lestini. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
-BHV-1510 is a novel trophoblast cell surface antigen-2 (Trop-2) directed antibody drug conjugate (ADC) that has demonstrated a highly differentiated...
-BHV-1510 is a novel trophoblast cell surface antigen-2 (Trop-2) directed antibody drug conjugate (ADC) that has demonstrated a highly differentiate
/PRNewswire/ -- Pyramid Biosciences, Inc., a privately-held, clinical-stage biotechnology company focused on developing transformative medicines for patients...
PBI-200 is being developed for the treatment of NRTK fusion-positive solid tumors, including primary and metastatic brain tumorsPBI-200 is presently being evaluated in a global Phase 1/2 multicenter clinical trialWALTHAM, Mass.--(BUSINESS WIRE)--#NRTK--Pyramid Biosciences, Inc., a clinical-stage biotechnology compan...
/PRNewswire/ -- Pyramid Biosciences, Inc., and Caris Life Sciences® (Caris), today announced a collaboration to enhance identification of potential patients...